<DOC>
	<DOCNO>NCT01024140</DOCNO>
	<brief_summary>The primary aim pilot study test efficacy selective serotonin re-uptake inhibitor , Escitalopram , treatment posttraumatic stress disorder ( PTSD ) open clinical trial . A secondary aim determine whether treatment escitalopram increase plasma allopregnanolone level patient PTSD increase allopregnanolone level correlate treatment efficacy .</brief_summary>
	<brief_title>Open Trial Escitalopram Treatment Male Subjects With Posttraumatic Stress Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Current DSMIV TR PTSD score &gt; 40 CAPS , result traumatic event occur least 6 month prior evaluation . Lifetime history bipolar psychiatric disorder psychotic feature . Prominent suicidal homicidal ideation . History alcohol abuse/dependence within past 3 month . History drug abuse/dependence within past 6 month . Subjects plan start new form psychotherapy protocol . History sleep apnea , neurological disorder and/or current systemic illness affect central nervous system function . History myocardial infarction past year . Subjects antipsychotic medication , systemic steroid medication , antidepressant , mood stabilizer , antianxiety medication , benzodiazepine within past 2 week . Use Citalopram Escitalopram within past 6 month .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Efficacy</keyword>
</DOC>